Information Provided By: 
Fly News Breaks for October 18, 2016
TMO
Oct 18, 2016 | 09:49 EDT
Cleveland Research said recent work continues to indicate demand trends over the past few months remain soft as European government, U.S. academic, and global pharma companies have incrementally slowed their growth in R&D spending. Consequently, the firm continues to expect 3Q16 organic growth of 3% for Thermo Fisher but believes the company needs to raise FY16 guidance by 7c-9c to reflect FEI accretion. Cleveland rates Thermo Fisher a Neutral.
News For TMO From the Last 2 Days
TMO
Apr 25, 2024 | 08:51 EDT
Deutsche Bank raised the firm's price target on Thermo Fisher to $610 from $600 and keeps a Buy rating on the shares post the Q1 report. The analyst says a solid operational performance drove a strong start to 2024.
TMO
Apr 25, 2024 | 08:29 EDT
TMO
Apr 25, 2024 | 07:32 EDT
TMO
Apr 25, 2024 | 07:03 EDT
TMO
Apr 25, 2024 | 06:31 EDT
TMO
Apr 25, 2024 | 05:12 EDT
Barclays analyst Luke Sergott raised the firm's price target on Thermo Fisher to $615 from $590 and keeps an Equal Weight rating on the shares. The company reported a beat across the board, says the analyst, who sees the business stabilizing.
TMO
Apr 24, 2024 | 08:50 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here
TMO
Apr 24, 2024 | 06:11 EDT
TMO
Apr 24, 2024 | 06:09 EDT
TMO
Apr 24, 2024 | 06:02 EDT
